Neurobiology of resilience

Resilience and Mental Health: Challenges Across the Lifespan

Volumn , Issue , 2011, Pages 1-29

  Feder, Adriana ^a   Charney, Dennis ^a   Collins, Kate ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923786411     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511994791.003     Document Type: Chapter

References (275)

1. aan het Rot, M., Collins, K. A., & Fitterling, H. L. (2009). Physical exercise and depression. Mount Sinai Journal of Medicine, 76,204-214.
2. Affleck, G. & Tennen, H. (1996). Construing benefits from adversity: Adaptational significance and dispositional underpinnings. Journal of Personality, 64, 899-922.
3. Alfinito, P. D., Chen, X., Mastroeni, R., Pawlyk, A. C., & Deecher, D. C. (2009). Estradiol increases catecholamine levels in the hypothalamus of ovariectomized rats during the dark-phase. European Journal of Pharmacology, 616, 334-339.
4. Alim, T. N., Feder, A., Graves, R. E., etal. (2008). Trauma, resilience, and recovery in a high-risk African-American population. American Journal of Psychiatry, 165,1566-1575.
5. Anestis, S. F. (2006). Testosterone in juvenile and adolescent male chimpanzees (Pan troglodytes): effects of dominance rank, aggression, and behavioral style. American Journal of Physical Anthropology, 130,536-545.
6. Baker, D. G., West, S. A., Orth, D. N., etal. (1997). Cerebrospinal fluid and plasma beta-endorphin in combat veterans with post-traumatic stress disorder. psychoneuroendocrinology, 22,517-529.
7. Baker, D. G., West, S. A., Nicholson, W. E., etal. (1999). Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. American Journal of Psychiatry, 156, 585-588.
8. Baker, D. G., Ekhator, N. N., Kasckow, J. W., etal. (2005). Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. American Journal of Psychiatry, 162, 992-994.
9. Bakshi, V. P., Smith-Roe, S., Newman, S. M., Grigoriadis, D. E., & Kalin, N. H. (2002). Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. Journal of Neuroscience, 22, 2926-2935.
10. Bale, T. L., Contarino A., Smith, G. W., etal. (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genetics, 24,410-414.
11. Bannon, A. W., Seda, J., Carmouche, M., etal. (2000). Behavioral characterization of neuropeptide Y knockout mice. Brain Research, 868,79-87.
12. Barrera, G., Hernandez, A., Poulin, J. F., etal. (2006). Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. Synapse, 59,27-40.
13. Bast, T. (2007). Toward an integrative perspective on hippocampal function: From the rapid encoding of experience to adaptive behavior. Reviews in the Neurosciences, 18,253-281.
14. Bastianetto, S., Ramassamy, C., Poirier, J., & Quirion, R. (1999). Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Research, MolecularBrain Research, 66,35-41.
15. 2 dopamine receptors regulate immobilization stress- induced activation of the hypothalamus-pituitary- adrenal axis. Psychopharmacology (Berl), 206, 355-365.
16. Belfer, I., Hipp, H., McKnight, C., et al. (2006). Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Molecular Psychiatry, 11, 301-311.
17. Belsky, J., Jonassaint, C., Pluess, M., etal. (2009). Vulnerability genes or plasticity genes? Molecular Psychiatry, 14,746-754.
18. Bender, N., Heg, D., Hamilton, I. M., etal. (2006). He relationship between social status, behaviour, growth and steroids in male helpers and breeders of a cooperatively breeding cichlid. Hormones and Behavior, 50,173-182.
19. Berton, O., McClung, C. A., Dileone, R. J., etal. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311,864-868.
20. Berton, O., Covington, H. E. 3rd, Ebner, K., etal. (2007). Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses. Neuron, 55,289-300.
21. Bethea, C. L., Mirkes, S. J., Shively, C. A., & Adams, M. R. (2002). Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biological Psychiatry, 47, 562-576.
22. Bierer, L. M., Tischler, L., Labinsky, E., et al. (2006). Clinical correlates of 24-h cortisol and norepinephrine excretion among subjects seeking treatment following the World Trade Center attacks on 9/11. Annals of the New York Academy of Sciences, 1071, 514-520.
23. 1 receptor but not cell proliferation in a rat model of depression. Hippocampus, 20, 820-828.
24. Block, J. & Kremen, A. M. (1996). IQ andego-resiliency: Conceptual and empirical connections and separateness. Journal of Personality and Social Psychology, 70, 349-361.
25. Blomqvist, A. G. & Herzog, H. (1997). Y-receptor subtypes - how many more? Trends in Neuroscience, 20,294-298.
26. Bogdan, R. & Pizzagalli, D. A. (2006). Acute stress reduces reward responsiveness: Implications for depression. Biological Psychiatry, 60,1147-1154.
27. Bonanno, G. A. (2004). Loss, trauma, and human resilience: Have we underestimated the human capacity to thrive after extremely aversive events? American Psychologist, 59,20-28.
28. Boyer, E. W. & Shannon, M. (2005). The serotonin syndrome. New England Journal of Medicine, 352,1112-1120.
29. Bradley, R. G., Binder, E. B., Epstein, M. P., et al. (2008). Influence of child abuse on adult depression: Moderation by the corticotropin-releasing hormone receptor gene. Archives of General Psychiatry, 65,190-200.
30. Bremner, J. D., Krystal, J. H., Southwick, S. M., & Charney, S. (1996). Noradrenergic mechanisms in stress and anxiety: I. preclinical studies. Synapse, 23,28-38.
31. Bremner, J. D., Licinio, J., Darnell, A., etal. (1997). Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. American Journal of Psychiatry, 154, 624-629.
32. Britton, K. T., Akwa, Y., Spina, M. G., & Koob, G. F. (2000). Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze. Peptides, 21, 37-44.
33. Browne, E. S., Wright, B. E., Porter, J. R., & Svec, F. (1992). Dehydroepiandrosterone: Antiglucocorticoid action in mice. American Journal of Medical Science, 303, 366-371.
34. Brunner, R., Schaefer, D., Hess, K., et al. (2006). Effect of high-dose cortisol on memory functions. Annals of the New York Academy of Sciences, 1071,434-437.
35. Butler, L. D., Koopman, C., Azarow, J., etal. (2009). Psychosocial predictors of resilience after the September 11, 2001 terrorist attacks. Journal of Nervous and Mental Disorders, 197,266-273.
36. Carey, M. P., Deterd, C. H., de Koning, J., Helmerhorst, F., & de Kloet, E. R. (1995). The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. Journal of Endocrinology, 144, 311-321.
37. Caria, A., Veit, R., Sitaram, R., etal. (2007). Regulation of anterior insular cortex activity using real-time fMRI. Neuroimage 35,1238-1246.
38. Carroll, B. J., Cassidy, F., Naftolowitz, D., etal. (2007). Pathophysiology of hypercortisolism in depression. Acta PsychiatricScandinavica Supplement, 433,90-103.
39. Carter, R. M., Macinnes, J. J., Huettel, S. A., & Adcock, R. A. (2009). Activation in the VTA and nucleus accumbens increases in anticipation of both gains and losses. Frontiers in Behavioral Neuroscience, 3,21.
40. Caspi, A., Sugden, K., Moffitt, T. E., et al. (2003). Influence oflife stress on depression: Moderation by a polymorphism in the 5-HTTgene. Science, 301, 386-389.
41. Chang, E., Maydeu-Olivares, A., & D'Zurilla, T. J. (1997). Optimism and pessimism as partially independent constructs: Relationship to positive and negative affectivity and psychological well-being. Personality and Individual Differences, 23,433-440.
42. Charney, D. S. (2004). Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. American Journal of Psychiatry, 161,195-216.
43. Charney, D. S. & Bremner, J. D. (1999). The neurobiology of anxiety disorders. In D. S. Charney, E. J. Nestler, & B. S. Bunney (eds.), Neurobiology of mental illness (pp. 494-517). New York: Oxford University Press.
44. Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987). Neuro biological mechanisms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks. American Journal of Psychiatry, 144,1030-1036.
45. Charney, D. S., Woods, S. W., Krystal, J. H., Nagy, L. M., & Heninger, G. R. (1992). Noradrenergic neuronal dysregulation in panic disorder: The effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatric Scandinavica, 86,273-282.
46. Chen, L., Dai, X. N., & Sokabe, M. (2006). Chronic administration of ehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of longterm potentiation via sigma 1 (sigma1) receptor: Optical imaging study in rat hippocampal slices. Neuropharmacology, 50, 380-392.
47. Chida, Y. & Hamer, M. (2008). Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: A quantitative review of 30 years of investigations. Psychological Bulletin, 134, 829-885.
48. Coan, J. A., Schaefer, H. S., & Davidson, R. J. (2006). Lending a hand: Social regulation of the neural response to threat. Psychological Science, 17,1032-1039.
49. Colangelo, L. A., Sharp, L., Kopp, P., et al. (2007). Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: he CARDIA male hormone study. Psychoneuroendocrinology, 32,951-958.
50. Colucci, W. S., Gimbrone, M. A. Jr., McLaughlin, M. K., Halpern, W., & Alexander, R. W. (1982). Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circulation Research, 50, 805-811.
51. Conrad, M. & Hammen, C. (1989). Role of maternal depression in perceptions of child maladjustment. Journal of Consulting and Clinical Psychology, 57,663-667.
52. Cools, R., Calder, A. J., Lawrence, A. D., et al. (2005). Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology (Berl), 180, 670-679.
53. Cools, R., Roberts, A. C., & Robbins, T. W. (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends in Cognitive Science, 12, 31-40.
54. Coste, S. C., Kesterson, R. A., Heldwein, K. A., et al. (2000). Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin- releasing hormone receptor-2. Nature Genetics, 24, 403-409.
55. Cucinelli, F, Soranna, L., Barini, A., etal. (2002). Estrogen treatment and body fat distribution are involved in corticotropin and cortisol response to corticotropin- releasing hormone in postmenopausal women. Metabolism, Clinical and Experimental, 51,137-143.
56. Czoty, P. W., Gould, R. W., & Nader, M. A. (2009). Relationship between social rank and cortisol and testosterone concentrations in male cynomolgus monkeys (Macaca fascicularis). Journal of Neuroendocrinology, 21,68-76.
57. Daly, R. C., Su, T. P, Schmidt, P. J., etal. (2001). Cerebrospinal fluid and behavioral changes after methyltestosterone administration: Preliminary findings. Archives of General Psychiatry, 58,172-177.
58. Davis, M. & Whalen, P. J. (2001). The amygdala: Vigilance and emotion. Molecular Psychiatry, 6,13-34.
59. Dayan, P. & Huys, Q. J. (2009). Serotonin in affective control. Annual Reviews in the Neurosciences, 32, 95-126.
60. de Kloet, E. R., Joels, M., & Holsboer, F. (2005). Stress and the brain: From adaptation to disease. Nature Reviews in the Neurosciences, 6,463-475.
61. de Kloet, E. R., Derijk, R. H., & Meijer, O. C. (2007). herapy insight: Is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nature Clinical and Practical Endocrinology and Metabolism, 3,168-179.
62. Deaner, S. L. & McConatha, J. T. (1993). The relation of humor to depression and personality. Psychological Reports, 72,755-763.
63. Debiec, J. & LeDoux, J. E. (2006). Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: Treatment implications for PTSD. Annals of the New York Academy of Sciences, 1071, 521-524.
64. Dedovic, K., Renwick, R., Mahani, N. K., etal. (2005). he Montreal Imaging Stress Task: Using functional imaging to investigate the effects of perceiving and processing psychosocial stress in the human brain. Journal of Psychiatry and Neuroscience, 30, 319-325.
65. Delgado, M. R., Olsson, A., & Phelps, E. A. (2006). Extending animal models of fear conditioning to humans. Biological Psychology, 73,39-48.
66. Derijk, R. H. (2009). Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation, 16,340-352.
67. Derijk, R. H. & de Kloet, E. R. (2008). Corticosteroid receptor polymorphisms: Determinants of vulnerability and resilience. European Journal of Pharmacology, 583, 303-311.
68. Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007). Oxytocin improves “mind- reading” in humans. Biological Psychiatry, 61,731-733.
69. Douma, S. L., Husban D. C., O' Donnell, M. E., Barwin, B. N., & Woodend, A. K. (2005). Estrogen-related mood disorders: Reproductive life cycle factors. Advances in Nursing Science, 28, 364-375.
70. Drabant, E. M., Hariri, A. R., Meyer-Lindenberg, A., et al. (2006). Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry, 63,1396-1406.
71. Duman, R. S. & Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59,1116-1127.
72. Edwards, D. A., Wetzel, K., & Wyner, D. R. (2006). Intercollegiate soccer: Saliva cortisol and testosterone are elevated during competition, and testosterone is related to status and social connectedness with teammates. Physiology and Behavior, 87,135-143.
73. Edwards, D. A. & O'Neal, J. (2009). Oral contraceptives decrease saliva testosterone but do not affect the rise in testosterone associated with athletic competition. Hormones and Behavior, 56,195-198.
74. Eisch, A. J., Bolanos, C. A., de Wit, J., et al. (2003). Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression. Biological Psychiatry, 54, 994-1005.
75. Elder, G. H. Jr. (1998). The life course as developmental theory. Child Development, 69,1-12.
76. Elovainio, M., Jokela, M., Kivimaki, M., etal. (2007). Genetic variants in the DRD2 gene moderate the relationship between stressful life events and depressive symptoms in adults: Cardiovascular risk in Young Finns study. Psychosomatic Medicine, 69, 391-395.
77. Eva, C., Serra, M., Mele, P., Panzica, G., & Oberto, A. (2006). Physiology and gene regulation of the brain NPY Y1 receptor. Frontiers in Neuroendocrinology, 27, 308-339.
78. Felmingham, K., Kemp, A., Williams, L., etal. (2007). Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress disorder. Psychological Science, 18,127-129.
79. Flugge, G., Kramer, M., & Fuchs, E. (2001). Chronic subordination stress in male tree shrews: Replacement of testosterone affects behavior and central alpha(2)- adrenoceptors. Physiology and Behavior, 73,293-300.
80. Folkman, S. & Moskowitz, J. T. (2000). Positive affect and the other side of coping. American Psychology, 55, 647-654.
81. Forbes, E. E., Hariri, A. R., Martin, S. L., etal. (2009). Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. American Journal of Psychiatry, 166,64-73.
82. Franca, S. C., Barros Neto, T. L., Aqresta, M. C., Lotufo, R. F., & Kater, C. E. (2006). Divergent responses of serum testosterone and cortisol in athlete men after a marathon race. Arquivos Brasileiros de Endocrinologia e Metabologia, 50,1082-1087.
83. Fredrickson, B. L. (2001). The role ofpositive emotions in positive psychology. he broaden-and-build theory of positive emotions. American Psychologist, 56,218-226.
84. Gallagher, P. & Young, A. (2002). Cortisol/DHEA ratios in depression. Neuropsychopharmacology, 26,410.
85. Geracioti, T. D. Jr., Baker, D. G., Ekhator, N. N., etal. (2001). CSF norepinephrine concentrations in posttraumatic stress disorder. American Journal of Psychiatry, 158, 1227-1230.
86. Gillespie, N. A., Whitfield, J. B., Williams, B., Heath, A. C., & Martin, N. G. (2005). The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychological Medicine, 35,101-111.
87. Goldin, P. R., McRae, K., Ramel, W., & Gross, J. J. (2008). The neural bases of emotion regulation: Reappraisal and suppression of negative emotion. Biological Psychiatry, 63, 577-586.
88. Goldman, S. L., Kraemer, D. T., & Salovey, P. (1996). Beliefs about mood moderate the relationship of stress to illness and symptom reporting. Journal of Psychosomatic Research, 41,115-128.
89. Goldstein, L. E., Rasmusson, A. M., Bunney, B. S., & Roth, R. H. (1996). Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. Journal of Neuroscience, 16,4787-4798.
90. Goodyer, I. M., Herbert, J., & Altham, P. M. (1998). Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychological Medicine, 28,265-273.
91. Goyal, S. N., Upadhya, M. A., Kokare, D. M., Bhisikar, S. M., & Subhedar, N. K. (2009). Neuropeptide Ymodulates the antidepressant activity of imipramine in olfactory bulbectomized rats: Involvement of NPY Y1 receptors. Brain Research, 1266,45-53.
92. Green, S., Walter, P., Kumar, V., et al. (1986). Human oestrogen receptor cDNA: Sequence, expression and homology to v-Erb-A. Nature, 320,134-139.
93. Gross, C., Zhuang, X., Stark, K., et al. (2002). Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature, 416,396-400.
94. Gutman, A. R., Yang, Y., Ressler, K. J., & Davis, M.(2008). The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. Journal of Neuroscience, 28,12682-12690.
95. Handwerger, K. (2009). Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harvard Reviews of Psychiatry, 17, 184-205.
96. Heilig, M., McLeod, S., Brot, M., etal. (1993). Anxiolyticlike action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology, 8, 357-363.
97. Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994). Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration. Trends in Neuroscience, 17,80-85.
98. Heilig, M., Zachrisson, O., horsell, A., etal. (2004). Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: Preliminary evidence for association with preproNPY gene polymorphism. Journal of Psychiatric Research, 38,113-121.
99. Heim, C. & Nemeroff, C. B. (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biological Psychiatry, 49,1023-1039.
100. Heinz, A. & Smolka, M. N. (2006). The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Reviews in the Neurosciences, 17,359-367.
101. Heinz, A., Braus, D. F., Smolka, M. N., et al. (2005). Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nature Neuroscience, 8,20-21.
102. Heisler, L. K., Chu, H. M., Brennan, T. J., etal. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences of the USA, 95,15049-15054.
103. Hermans, E. J., Putman P., Baas, J. M., Koppeschaar, H. P., & van Honk, J. (2006). A single administration of testosterone reduces fear-potentiated startle in humans. Biological Psychiatry, 59,872-874.
104. Hermans, E. J., Putman P., Baas, J. M., etal. (2007). Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology, 32,1052-1061.
105. Hermans, E. J., Ramsey, N. F., & van Honk, J. (2008). Exogenous testosterone enhances responsiveness to social threat in the neural circuitry of social aggression in humans. Biological Psychiatry, 63,263-270.
106. Hilke, S., Theodorsson, A., Fetissov, S., et al. (2005). Estrogen induces a rapid increase in galanin levels in female rat hippocampal formation: Possibly a nongenomic/indirect effect. European Journal of Neuroscience, 21,2089-2099.
107. Hilke, S., Holm, L., Man, K., Hokfelt, T., & Theodorsson, (2009). Rapid change of neuropeptide Y levels and gene-expression in the brain of ovariectomized mice after administration of 17β-estradiol. Neuropeptides, 43, 327-332.
108. Hokfelt, T., Bröberger, C., Zhang, X., etal. (1998). Neuropeptide Y: Some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Research Reviews, 26,154-166.
109. Holmes, A. & Picciotto, M. R. (2006). Galanin: A novel therapeutic target for depression, anxiety disorders and drug addiction? CNS Neurology Disorders and Drug Targets 5, 225-232.
110. Holmes, A., Kinney, J. W., Wrenn, C. C., etal. (2003). Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology, 28,1031-1044.
111. Hopper, J. W., Pitman, R. K., Su, Z., et al. (2008). Probing reward function in posttraumatic stress disorder: Expectancy and satisfaction with monetary gains and losses. Journal of Psychiatric Research, 42, 802-807.
112. Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006). Neural mechanisms of addiction: he role of reward- related learning and memory. Annual Reviews in the Neurosciences, 29, 565-598.
113. Inoue, T., Koyama, T., & Yamashita, I. (1993). Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacology Biochemistry and Behavior, 44, 371-374.
114. Insel, T. R. (1997). A neurobiological basis of socialattachment. American Journal of Psychiatry, 154,726-735.
115. Inslicht, S. S., Marmar, C. R., Neylan, T. C., etal. (2006). Increased cortisol in women with intimate partner violence-related posttraumatic stress disorder. Annals of the New York Academy of Sciences, 1071,428-429.
116. Isen, A. M., Daubman, K. A., & Nowicki, G. P. (1987). Positive affect facilitates creative problem solving. Journal of Personality and Social Psychology, 52,1122-1131.
117. Jabbi, M., Korf, J., Kema, I. P., etal. (2007). Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Molecular Psychiatry, 12,483-490.
118. Johnstone, T., van Reekum, C. M., Urry, H. L., Kalin, N. H., & Davidson, R. J. (2007). Failure to regulate: Counterproductive recruitment of top-down prefrontal- subcortical circuitry in major depression. Journal of Neuroscience, 27,8877-8884.
119. Kaga, T., Inui, A., Okita, M., etal. (2001). Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding. Diabetes, 50, 1206-1210.
120. Karlsson, R. M. & Holmes, A. (2006). Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease. Amino Acids, 31,231-239.
121. Karlsson, R. M., Holmes, A., Heilig, M., & Crawley, J. N.(2006). Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacology, Biochemistry and Behavior, 80,427-436.
122. Khoshbouei, H., Cecchi, M., Dove, S., Javors, M., & Morilak, D. A. (2002). Behavioral reactivity to stress: Amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacology, Biochemistry and Behavior, 71, 407-417.
123. Kim, J. M., Stewart, R., Kim, S. W., etal. (2007). Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biological Psychiatry, 62,423-428.
124. Kimonides, V. G., Khatibi, N. H., Svendsen, C. N., Sofroniew, M. V., & Herbert, J. (1998). Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the USA, 95, 1852-1857.
125. Kirsch, P., Esslinger, C., Chen, Q., etal. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25,11489-11493.
126. Klangkalya, B. & Chan, A. (1988). The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Science, 42,2307-2314.
127. Klohnen, E. C. (1996). Conceptual analysis and measurement of the construct of ego-resiliency. Journal of Personality and Social Psychology, 70,1067-1079.
128. Komesaroff, P. A., Esler, M. D., & Sudhir, K. (1999). Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. Journal of Clinical Endocrinology and Metabolism, 84, 606-610.
129. Korte, S. M., Koolhaas, J. M., Wingfield, J. C., & McEwen, B. S. (2005). The Darwinian concept of stress: Benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neuroscience and BioBehavioral Reviews, 29, 3-38.
130. Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435,673-676.
131. Kozlovsky, N., Matar, M. A., Kaplan, Z., Zohar, J., & Cohen, H. (2009). The role of the galaninergic system in modulating stress-related responses in an animal model of posttraumatic stress disorder. Biological Psychiatry, 65, 383-391.
132. Krishnan, V., Han, M. H., Graham, D. L., etal. (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell, 131,391-404.
133. Krishnan, V., Han, M. H., Mazei-Robison, M., et al. (2008). AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biological Psychiatry, 64, 691-700.
134. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the USA, 93,5925-5930.
135. 2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder. European Psychiatry, 21,180-185.
136. Lazarus, R. S. (1991). Progress on a cognitive-motivational- relational theory of emotion. American Psychologist, 46, 819-834.
137. Lee, V., Cohen, S. R., Edgar, L., Laizner, A. M., & Gagnon, A. J. (2004). Clarifying “meaning” in the context of cancer research: A systematic literature review. Palliative Support Care, 2,291-303.
138. Lemieux, A. M. & Coe, C. L. (1995). Abuse-related posttraumatic stress disorder: Evidence for chronic neuroendocrine activation in women. Psychosomatic Medicine, 57,105-115.
139. Levenson, R. W. (2003). Blood, sweat, and fears: The autonomic architecture of emotion. Annals of the New York Academy of Sciences, 1000, 348-366.
140. Liberzon, I. & Sripada, C. S. (2008). The functional neuroanatomy of PTSD: A critical review. Progress in Brain Research, 167,151-169.
141. Lin, S., Boey, D., & Herzog, H. (2004). NPY and Y receptors: Lessons from transgenic and knockout models. Neuropeptides, 38,189-200.
142. Lopez, J. F., Chalmers, D. T., Little, K. Y., & Watson, S. J. (1998). A.E. Bennett Research Award. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biological Psychiatry, 43,547-573.
143. Lu, X., Ross, B., Sanchez-Alavez, M., Zorrilla, E. P., & Bartfai, T. (2008a). Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides, 42,387-397.
144. Lu, A., Steiner, M. A., Whittle, N., etal. (2008b). Conditional mouse mutants highlight mechanisms of corticotropin- releasing hormone effects on stress-coping behavior. Molecular Psychiatry, 13,1028-1042.
145. Lukkes, J., Vuong, S., Scholl, J., Oliver, H., & Forster, G. (2009). Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation. Journal of Neuroscience, 29,9955-9960.
146. Lyons, D. M. & Parker, K. J. (2007). Stress inoculation- induced indications of resilience in monkeys. Journal of Trauma and Stress, 20,423-433.
147. Maggi, A. & Perez, J. (1986). Estrogen-induced up-regulation of gamma-aminobutyric acid receptors in the CNS of rodents. Journal of Neurochemistry, 47,1793-1797.
148. Maier, S. F., Amat, J., Baratta, M. V., Paul, E., & Watkins, L. R. (1986). Behavioral control, the medial prefrontal cortexand resilience. Dialogues in Clinical Neuroscience, 8, 397-406.
149. Manne, S., Duhamel, K., Ostroff J., etal. (2003). Coping and the course of mother's depressive symptoms during and after pediatric bone marrow transplantation. Journal of the American Academy of Child and Adolescent Psychiatry, 42,1055-1068.
150. Masten, A. S. (2001). Ordinary magic. Resilience processes in development. American Psychologist, 56,227-238.
151. Masten, A. S. & Coatsworth, J. D. (1998). The development of competence in favorable and unfavorable environments. Lessons from research on successful children. American Psychologist, 53,205-220.
152. Masten, A. S., Coatsworth, J. D., Neemann, J., etal. (1995). he structure and coherence of competence from childhood through adolescence. Child Development, 66, 1635-1659.
153. McCabe, C., Cowen, P. J., & Harmer, C. J. (2009). Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl), 205, 667-677.
154. McEwen, B. S. (2002). Estrogen actions throughout the brain. Recent Progress in Hormonal Research, 57, 357-384.
155. McEwen, B. S. (2003). Mood disorders and allostatic load. Biological Psychiatry, 54,200-207.
156. McEwen, B. S. & Stellar, E. (1993). Stress and the individual: Mechanisms leading to disease. Archives of Internal Medicine, 153,2093-2101.
157. McGaugh, J. L. (2004). The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annual Reviews in the Neurosciences, 27,1-28.
158. Meaney, M. J. & Szyf, M. (2005). Environmental programming of stress responses through DNA methylation: Life at the interface between a dynamic environment and a fixed genome. Dialogues in Clinical Neuroscience, 7,103-123.
159. Mikkelsen, J. D. & Woldbye, D. P. (2006). Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke. Journal of Psychiatric Research, 40, 153-159.
160. Mize, A. L., Poisner, A. M., & Alper, R. H. (2001). Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin HT(1A) receptor function. Neuroendocrinology, 73, 166-174.
161. Mobbs, D., Greicius, M. D., Abdel-Azim, E., Menon, V., & Reiss, A. L. (2003). Humor modulates the mesolimbic reward centers. Neuron, 40,1041-1048.
162. Monk, C. S., Klein, R. G., Telzer, E. H., etal. (2008). Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. American Journal of Psychiatry, 165, 90-98.
163. Moran, J. M., Wig, G. S., Adams, R. B. Jr., Janata, P., & Kelley, W. M. (2004). Neural correlates of humor detection and appreciation. Neuroimage, 21,1055-1060.
164. Morfin, R. &Starka, L. (2001). Neurosteroid7-hydroxylation products in the brain. International Reviews in Neurobiology, 46,79-95.
165. Morgan, C. A. 3rd, Wang, S., Southwick, S. M. (1986), et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry, 47, 902-909.
166. Morgan, C. A. 3rd, Southwick, S., Hazlett, G., et al. (2004). Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress. Archives of General Psychiatry, 61, 819-825.
167. Morrow, B. A., Elsworth, J. D., Rasmusson, A. M., & Roth, R. H. (1999). The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience, 92,553-564.
168. Moses, E. L., Drevets, W. C., Smith, G., etal. (2000). Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study. Biological Psychiatry, 48,854-860.
169. Munafo, M. R., Brown, S. M., & Hariri, A. R. (2008). Serotonin transporter (5-HTTLPR) genotype and amygdala activation: A meta-analysis. Biological Psychiatry, 63,852-857.
170. Munafo, M. R., Durrant, C., Lewis, G., & Flint, J. (2009). Gene X environment interactions at the serotonin transporter locus. Biological Psychiatry, 65,211-219.
171. Munn, M. A., Alexopoulos, J., Nishino, T., etal. (2007). Amygdala volume analysis in female twins with major depression. Biological Psychiatry, 62,415-422.
172. Nemeroff C. B. (2002). Recent advances in the neurobiology of depression. Psychopharmacological Bulletin, 36(Suppl 2), 6-23.
173. Nestler, E. J. & Carlezon, W. A. Jr. (2006). he mesolimbic dopamine reward circuit in depression. Biological Psychiatry, 59,1151-1159.
174. Neumeister, A., Charney, D. S., Belfer, I., etal. (2005). Sympathoneural and drenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenetics and Genomics, 15,143-149.
175. New, A. S., Fan J., Murrough, J. W., et al. (2009). A functional magnetic resonance imaging study of deliberate emotion regulation in resilience and posttraumatic stress disorder. Biological Psychiatry, 66, 656-664.
176. Nikisch, G. & Mathe, A. A. (2008). CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. European Psychiatry, 23,356-359.
177. Nikisch, G., Agren, H., Eap, C. B., et al. (2005). Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. International Journal of Neuropsychopharmacology, 8,403-410.
178. Nitschke, J. B., Sarinopoulos I., Oathes, D. J., etal. (2009). Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. American Journal of Psychiatry, 166,302-310.
179. Ochsner, K. N., Ray, R. D., Cooper, J. C., et al. (2004). For better or for worse: Neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage. 23, 483-499.
180. O'Connor, D. B. (2002). Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiology and Behavior, 75,557-566.
181. Oliveira, T., Gouveia, M. J., & Oliveira, R. F. (2009). Testosterone responsiveness to winning and losing experiences in female soccer players. Psychoneuroendocrinology, 34,1056-1064.
182. Orr, S. P., Milad, M. R., Metzger, L. J., et al. (2006). Effects of beta blockade, PTSD diagnosis, and explicit threat on the extinction and retention of an aversively conditioned response. Biological Psychology, 73,262-271.
183. Otte, C., Neylan, T. C., Pole, N., etal. (2005). Association between childhood trauma and catecholamine response to psychological stress in police academy recruits. Biological Psychiatry, 57,27-32.
184. Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., & Toth, M.(1998). Increased anxiety of mice lacking the serotonin 1A receptor. Proceedings of the National Academy of Sciences of the USA, 95,10734-10739.
185. Pascucci, T., Ventura, R., Latagliata, E. C., Cabib, S., & Puglisi-Allegra, S. (2007). The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine. Cerebral Cortex, 17,2796-2804.
186. Pattij, T., Groenink, L., Hijzen, T. H., et al. (2002). Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. Neuropsychopharmacology, 27, 380-390.
187. Pecins-hompson, M., Brown, N. A., & Bethea, C. L. (1998). Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Research, Molecular Brain Research, 53,120-129.
188. Perez, S. E., Wynick, D., Steiner, R. A., & Mufson, E. J.(2001). Distribution of galaninergic immunoreactivity in the brain of the mouse. Journal of Comparative Neurology, 434,158-185.
189. Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., etal. (2005). 5-HTTLPR polymorphism impacts human cingulate- amygdala interactions: A genetic susceptibility mechanism for depression. Nature Neuroscience, 8,828-834.
190. Pfeifer, J. H., Iacoboni, M., Mazziotta, J. C., & Dapretto, M. (2005). Mirroring others' emotions relates to empathy and interpersonal competence in children. Neuroimage, 39,2076-2085.
191. Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003a). Neurobiology of emotion perception, I: he neural basis of normal emotion perception. Biological Psychiatry, 54, 504-514.
192. Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003b). Neurobiology of emotion perception, II: Implications for major psychiatric disorders. Biological Psychiatry, 54, 515-528.
193. Pitman, R. K., Sanders, K. M., Zusman, R. M., etal. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry, 51, 189-192.
194. Pizzagalli, D. A., Holmes, A. J., Dillon, D. G., et al. (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. American Journal of Psychiatry, 166,702-710.
195. Pope, H. G. Jr., Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57,133-140; discussion 155-156.
196. Power, M. & Dalgleish, T. (1997). Cognition and emotion from order to disorder. New York: Taylor and Francis.
197. Puglisi-Allegra, S., Kempf, E., & Cabib, S. (1990). Role of genotype in the adaptation of the brain dopamine system to stress. Neuroscience, BioBehavioral Reviews, 14,523-528.
198. Puglisi-Allegra, S., Imperato, A., Angelucci, L., & Cabib, S. (1991). Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Research, 554, 217-222.
199. Raap, D. K., DonCarlos, L., Garcia, F., et al. (2000). Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology, 39,1823-1832.
200. Rabkin, J. G., McElhiney, M. C., Rabkin, R., McGrath, P. J., & Ferrando, S. J. (2006). Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. American Journal of Psychiatry, 163, 59-66.
201. Raine, A. & Yang, Y. (2006). Neural foundations to moral reasoning and antisocial behavior. Social Cognitive and Affective Neuroscience, 1,203-213.
202. Rajarao, SJR., Platt, B., Sukoff, S. J., et al. (2007). Anxiolyticlike activity of the non-selective galanin receptor agonist, galnon. Neuropeptides, 41,307-320.
203. Rasmusson, A. M., Vasek, J., Lipschitz, D. S., etal.(2001). An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacology, 29,1546-1557.
204. Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research- past, present, and future. Biological Psychiatry, 60,376-382.
205. Reed, J. & Love, S. (2009). Army developing masterresiliency training. Military Health System News, August 17. Washington, DC: Department of Defense, http://www.health.mil/News_And_Multimedia/News/detail/09-08-17/Army_Developing_Master_Resiliency_Training.aspx (accessed February 16, 2011).
206. Risch, N., Herrell, R., Lehner, T., etal. (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A metaanalysis. Journal of the American Medical Association, 301,2462-2471.
207. Rizzolatti, G. & Craighero, L. (2004). The mirror-neuron system. Annual Reviews in the Neurosciences, 27, 169-192.
208. Rose, K. A., Stapleton, G., Dott, K., etal. (1997). Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proceedings of the National Academy of Sciences of the USA, 94,4925-4930.
209. Rosenfeld, R. S., Hellman, L., Roffwarg, H., etal. (1971). Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. Journal of Clinical Endocrinology and Metabolism, 33,87-92.
210. Rutter, M. (1985). Resilience in the face of adversity. protective factors and resistance to psychiatric disorder. British Journal of Psychiatry, 147,598-611.
211. Rutter, M. (2006). Implications of resilience concepts for scientific understanding. Annals of the New York Academy of Sciences, 1094,1-12.
212. Sah, R., Ekhator, N. N., Strawn, J. R., et al. (2009). Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biological Psychiatry, 66, 705-707.
213. Sailer, U., Robinson, S., Fischmeister, F. P., etal. (2008). Altered reward processing in the nucleus accumbens and mesial prefrontal cortex of patients with posttraumatic stress disorder. Neuropsychologia, 46,2836-2844.
214. Sajdyk, T. J., Johnson, P. L., Leitermann, R. J., etal. (2008). Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. Journal of Neuroscience, 28,893-903.
215. Sanchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R.(1995). Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. Journal of Comparative Neurology, 408,365-377.
216. Schelling, G., Roozendaal, B., Krauseneck, T., etal. (2006). Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery. Annals of the New York Academy of Sciences, 1071,46-53.
217. Schulte-Ruther, M., Markowitsch, H. J., Fink, G. R., & Piefke, M. (2007). Mirror neuron and theory of mind mechanisms involved in face-to-face interactions: A functional magnetic resonance imaging approach to empathy. Journal of Cognitive Neuroscience, 19, 1354-1372.
218. Setchell, J. M., Smith, T., Wickings, E. J., & Knapp, L. A. (2007). Social correlates of testosterone and ornamentation in male mandrills. Hormones and Behavior, 54, 365-372.
219. Sevcik, J., Finta, E. P., & Illes, P. (1993). Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with μ-opioid receptors. European Journal of Pharmacology, 230,223-230.
220. Sharot, T., Riccardi, A. M., Raio, C. M., & Phelps, E. A.(1995). Neural mechanisms mediating optimism bias. Nature, 450,102-105.
221. Sibille, E., Pavlides, C., Benke, D., & Toth, M. (2000). Genetic inactivation of the serotonin(lA) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. Journal of Neuroscience, 20,2758-2765.
222. Siegrist, J., Menrath, I., Stocker, T., et al. (2005). Differential brain activation according to chronic social reward frustration. Neuroreport, 16,1899-1903.
223. Silver, J. M., Sandberg, D. P., & Hales, R. E. (1990). New approaches in the pharmacotherapy of posttraumatic stress disorder. Journal of Clinical Psychiatry, 51 (Suppl), 33-38; discussion 44-46.
224. Simson, P. E. & Weiss, J. M. (1988). Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology, 1,287-295.
225. Skuse, D. H. & Gallagher, L. (2009). Dopaminergic-neuropeptide interactions in the social brain. Trends in Cognitive Science, 13,27-35.
226. Smolka, M. N., Schumann, G., Wrase, J., etal. (2005). Catechol-O-methyltransferase VAL158MET genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Journal of Neuroscience, 25,836-842.
227. Solomon, M. B. & Herman, J. P. (2009). Sex differences in psychopathology: Of gonads, adrenals and mental illness. Physiology and Behavior, 97,250-258.
228. Southwick, S. M., Krystal, J. H., Bremner, J. D., etal. (1997). Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry, 54,749-758.
229. Southwick, S. M., Vythilingam, M., & Charney, D. S. (2005). The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annual Reviews in Clinical Psychology, 1,255-291.
230. Sterling, P & Eyer, J. (1988). Allostasis: Anewparadigmto explain arousal pathways. In S. R. Fisher (ed.), Handbook of life stress, cognition, and health (pp. 629-649). New York: Wiley.
231. Storm, E. E. & Tecott, L. H. (2005). Social circuits: Peptidergic regulation of mammalian social behavior. Neuron, 47, 483-486.
232. Su, T. P., Pagliaro, M., Schmidt, P. J., etal. (1993). Neuropsychiatric effects of anabolic steroids in male normal volunteers. Journal of the American Medical Association, 269, 2760-2764.
233. Swanson, C. J., Blackburn, T. P., Zhang, X., etal. (2006). Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889and SNAP 398. Proceedings of the National Academy of Sciences of the USA, 102,17489-17494.
234. Tache, Y. & Bonaz, B. (2007). Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. Journal of Clinical Investigation, 117, 33-40.
235. Terburg, D., Morgan, B., & van Honk, J. (2009). The testosterone-cortisol ratio: A hormonal marker for proneness to social aggression. International Journal of Law Psychiatry, 32,216-223.
236. hiiele, T. E., Marsh, D. J., St. Marie, L., Bernstein, I. L., & Palmiter, R. D. (1998). Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396, 366-369.
237. hiorson, J. A. & Powell, F. C. (1994). Depression and sense of humor. Psychological Reports, 75,1473-1474.
238. Tiet, Q. Q., Bird, H. R., Davies, M., et al. (1998). Adverse life events and resilience. Journal of American Academy of Child and Adolescent Psychiatry, 37,1191-1200.
239. Ulrich-Lai, Y. M., & Herman, J. P. (2009). Neural regulation of endocrine and autonomic stress responses. Nature Reviews in the Neurosciences, 10,397-409.
240. Unschuld, P. G., Ising, M., Erhardt, A., et al. (2008). Polymorphisms in the galanin gene are associated with symptom severity in female patients suffering from panic disorder. Journal of Affective Disorders, 105,177-184.
241. Vaillant, G. E. (1992). Ego mechanisms of defense: A guide for clinicians and researchers. Washington, DC: American Psychiatric Press.
242. van Honk, J. & Schutter, D. J. (2007). Testosterone reduces conscious detection of signals serving social correction: Implications for antisocial behavior. Psychological Science, 18, 663-667.
243. van Honk, J., Tuiten, A., Verbaten, R., et al. (1999). Correlations among salivary testosterone, mood, and selective attention to threat in humans. Hormones and Behavior, 36,17-24.
244. van Honk, J., Peper, J. S., & Schutter, DJLG. (2005). Testosterone reduces unconscious fear but not consciously experienced anxiety: Implications for the disorders of fear and anxiety. Biological Psychiatry, 58, 218-225.
245. Verhagen, M., van derMeij, A., Janzing, J. G., etal. (2009). Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disorders. Psychiatric Genetics, 19, 39-44.
246. Voisey, J., Swagell, C. D., Hughes, I. P., etal. (2009). The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans. Depression and Anxiety, 26,28-33.
247. Vreeburg, S. A., Hoogendijk, W. J., van Pelt, J., et al. (2009). Major depressive disorder and hypothalamic-pituitary- adrenal axis activity: Results from a large cohort study. Archives of General Psychiatry, 66, 617-626.
248. Vythilingam, M., Nelson, E. E., Scaramozza, M., etal.(1119). Reward circuitry in resilience to severe trauma: An fMRI investigation of resilient special forces soldiers. Psychiatry Research: Neuroimaging, 172,75-77.
249. Wager, T. D., Davidson, M. L., Hughes, B. L., Lindquist, M. A., & Ochsner, K. N. (2008). Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron, 59,1037-1050.
250. Walton, K. M., Chin, J. E., Duplantier, A. J., & Mather, R. J. (2008). Galanin function in the central nervous system. Current Opinions in DrugDiscovory and Development, 9, 560-570.
251. Waselus, M., Nazzaro, C., Valentino, R. J., & VanBockstaele, E. J. (2009). Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biological Psychiatry, 66,76-83.
252. Watt, M. J., Burke, A. R., Renner, K. J., & Forster, G. L. (2009). Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults. Behavioral Neuroscience, 123, 564-576.
253. Weaver, I. C., Cervoni, N., Champagne, F. A., et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7, 847-854.
254. Weis, F., Kilger, E., Roozendaal, B., etal. (2006). Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: A randomized study. Journal of horacic and Cardiovascular Surgery, 131,277-282.
255. Weiser, M. J., Foradori, C. D., & Handa, R. J. (2008). Estrogen receptor beta in the brain: From form to function. Brain Research Reviews, 57, 309-320.
256. Weiskopf, N., Scharnowski, F., Veit, R., etal. (2004). Self-regulation of local brain activity using real-time functional magnetic resonance imaging (fMRI). Journal of Physiology, 98,357-373.
257. Wheler, G. H., Brandon, D., Clemons, A., et al. (2006). Cortisol production rate in posttraumatic stress disorder. Journal of Clinical Endocrinology and Metabolism, 91, 3486-3489.
258. Whitworth, J. A., Williamson, P. M., Mangos, G., & Kelly, J. J.(1991). Cardiovascular consequences of cortisol excess. Vascular Health and Risk Management, 1,291-299.
259. Wilkinson, M. B., Xiao, G., Kumar, A., et al. (2009). Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. Journal of Neuroscience, 29, 7820-7832.
260. Willert, M. V., hiulstrup, A. M., & Hertz, J. (2009). Changes in stress and coping from a randomized controlled trial of a three-month stress management intervention. Scandinavian Journal of Work and Environmental Health, 35,145-152.
261. Wirth, M. M. & Schultheiss, O. C. (2007). Basal testosterone moderates responses to anger faces in humans. Physiology and Behavior, 90,496-505.
262. Wolfensberger, SPA., Veltman, D. J., Hoogendijk, WJG., Boomsma, D. I., & de Geus, EJC. (2008). Amygdala responses to emotional faces in twins discordant or concordant for the risk for anxiety and depression. Neuroimage, 41,544-552.
263. Wong, M. L., Kling, M. A., Munson, P. J., etal. (2000). Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proceedings of the National Academy of Sciences of the USA, 97, 325-330.
264. Xu, Z. Q., Tong, Y. G., & Hökfelt, T. (2001). Galanin enhances noradrenaline-induced outward current on locus coeruleus noradrenergic neurons. Neuroreport, 12, 1779-1782.
265. Yehuda, R. & LeDoux, J. (2007). Response variation following trauma: A translational neuroscience approach to understanding PTSD. Neuron, 56,19-32.
266. Yehuda, R., Boisoneau, D., Lowy, M. T., & Ciller, E. L. Jr. (1995). Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Archives of General Psychiatry, 52,583-593.
267. Yehuda, R., Brand, S. R., Golier, J. A., & Yang, R. K. (2006a). Clinical correlates of DHEA associated with posttraumatic stress disorder. Acta Psychiatrica Scandinavica, 114,187-193.
268. Yehuda, R., Brand, S., & Yang, R. K. (2006b). Plasma neuropeptide Y concentrations in combat exposed veterans: Relationship to trauma exposure, recovery from PTSD, and coping. Biological Psychiatry, 59, 660-663.
269. Young, A. H., Gallagher, P., & Porter, R. J. (2002). Elevation of the cortisol-dehydroepiandrosterone ratio in drug- free depressed patients. American Journal of Psychiatry, 159, 1237-1239.
270. Young, E. A. (1996). Sex differences in response to exogenous corticosterone: A rat model of hypercortisolemia. MolecularPsychiatry, 1, 313-319.
271. Young, E. A., Altemus, M., Parkison, V., & Shastry, S.(1991). Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology, 25, 881-891.
272. Yu, Y. Z. & Shi, J. X. (2009). Relationship between levels of testosterone and cortisol in saliva and aggressive behaviors of adolescents. Biomedical and Environmental Science, 22,44-49.
273. Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., & Kommor, M.(2009). Testosterone and depression: Systematic review and meta-analysis. Journal of Psychiatric Practice, 15,289-305.
274. Zitzmann, M. (2006). Testosterone and the brain. Aging Male, 9,195-199.
275. Zitzmann, M. & Nieschlag, E. (2001). Testosterone levels in healthy men and the relation to behavioural and physical characteristics: Facts and constructs. European Journal of Endocrinology, 144, 183-197.